Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients
Condition:   Hospitalized Patients Intervention:   Drug: Nirmatrelvir-Ritonavir Sponsors:   First People's Hospital of Hangzhou;   Hangzhou Cancer Hospital;   First People's Hospital of Lin'an District;   First People's Hospital of Yuhang District Recruiting (Source:
Source: - March 1, 2023 Category: Research Source Type: clinical trials

Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy
Condition:   Liver Cancer Interventions:   Drug: Bevacizumab;   Drug: Atezolizumab;   Drug: Sofosbuvir;   Drug: Velpatasvir;   Drug: Voxilaprevir;   Drug: Ribavirin Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI) Not yet recruiting (Source:
Source: - February 8, 2023 Category: Research Source Type: clinical trials